Journal profile · Surgery
Journal of Surgical Oncology
ISSN 0022-4790 · eISSN 1096-9098 · Wiley-Liss Inc. · UNITED STATES · Semimonthly
Journal of Surgical Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 1.94; hybrid open access; APC about USD 4,570; median 93 days to acceptance (92 articles, last 24 months); community-reported acceptance: about 50%; 306 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Surgical Oncology is published by Wiley-Liss Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Gastric Cancer Management and Outcomes and Hepatocellular Carcinoma Treatment and Prognosis, together about 21.8% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.
From the journal's Aims & Scope
Research area (LetPub): Surgery
Editor-in-chief Laleh G. MelstromPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine7.6%
- Gastric Cancer Management and OutcomesMedicine7.3%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine7%
- Pancreatic and Hepatic Oncology ResearchMedicine6.8%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.5%
- Colorectal Cancer Surgical TreatmentsMedicine6%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine5.1%
- Esophageal Cancer Research and TreatmentMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
| Minor | Surgery | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ESCIWeb of ScienceMEDLINEPubMedEmbaseCASCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.94LetPub ·
- Impact factor (publisher)
- 1.9Publisher website ·
- Impact factor (publisher) 2025
- 1.9Publisher website ·
- CiteScore 2026-06
- 3.7LetPub ·
- CiteScore (publisher)
- 3.7Publisher website ·
- CiteScore (publisher) 2025
- 3.7Publisher website ·
- SJR 2026-06
- 0.7LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 101LetPub ·
- h-index
- 156OpenAlex ·
- i10-index
- 6,897OpenAlex ·
- 2-year mean citedness
- 2.05OpenAlex ·
- Self-citation rate
- 5.3%LetPub ·
- Share of gold OA articles
- 31.57%LetPub ·
Volume
- Articles per year
- 217LetPub ·
- Articles per year (publisher) 2025
- 261Publisher website ·
- Downloads per year (publisher) 2025
- 525,049Publisher website ·
Articles by year OpenAlex count · 14,038 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 244 | 162 | 42 |
| 2025 | 306 | 160 | 423 |
| 2024 | 496 | 310 | 1,675 |
| 2023 | 408 | 260 | 2,271 |
| 2022 | 402 | 135 | 2,923 |
| 2021 | 475 | 139 | 4,582 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
93 daysMedian, submission to acceptance · P25–P75 37 days – 162 days
- Acceptance to online
- median 15 days (92 articles)
- Submission to online
- median 120 days
- Sample
- 92 articles with submission and acceptance dates (703 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Acceptance rate (publisher)
- 13%Publisher website ·
- Acceptance rate (publisher) 2025
- 13%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to first decision 2025
- 6 daysPublisher website ·
- Submission to acceptance 2025
- 84 daysPublisher website ·
- Acceptance to publication 2025
- 19 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,570 / EUR 3,770 / GBP 3,030 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Keywords
- ≤ 7
- Manuscript length
- ≤ 1,000 words
- Reference style
- Vancouver
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
- Not considered
- case reports
Article types accepted5
- case reportsCase Reports. Case reports are peer-reviewed and generally not published unless they represent a new technique or an oncologic concept of significant merit.Length not stated
- commentaryCommentary. Invited commentary of an accepted manuscript. Text must be less than 1 double-spaced page and contain no references.Length not stated
- editorialEditorial. Invited editorial of an accepted manuscript. Text must be 3-5 double-spaced pages and contain less than 5 references.Length not stated
- how i do itHow I Do It. Brief communications of authors' innovations in clinical or research techniques that simplify procedures or improve results are invited.Length not stated
- letters to the editorLetters to the Editor. Brief reports or letters regarding articles published in the Journal, concisely written in an objective, constructive fashion, will be co…Length not stated
Policy excerpts from the journal's websiteData availability, Peer review, Plagiarism
- Data availability Data Sharing and Data Accessibility
Please review Wiley’s policy here. This journal expects data sharing.
Source ↗Publisher website ·- Peer review Submission and Peer Review Process
New submissions should be made via the Wiley Authors submission portal. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review ou…
Source ↗Publisher website ·- Plagiarism
Plagiarism detection via CrossCheck Model summary
Please note manuscript submissions are now submitted for plagiarism detection through CrossCheck.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Liss Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Semimonthly
- ISSN
- 0022-4790
- Electronic ISSN
- 1096-9098
- Latest issue on the website
- Volume 134, Issue 4 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Journal of Surgical Oncology
What CAS zone is Journal of Surgical Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Surgical Oncology is in Zone 3 of Medicine, and in Zone 4 of the minor category Oncology / Surgery. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Surgical Oncology?
The latest impact factor listed by LetPub is 1.94; CiteScore 3.7, h-index 156.
How long does peer review take at Journal of Surgical Oncology?
Based on the dates recorded on 92 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 37–162 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 50%”; the journal's website gives an acceptance rate of 13% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Surgical Oncology?
According to the journal's author guidelines: Keywords: ≤ 7; Manuscript length: ≤ 1,000 words; Reference style: Vancouver; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Journal of Surgical Oncology?
According to LetPub and DOAJ records, Journal of Surgical Oncology is indexed in SCIE and Scopus. The journal's website also lists ESCI, Web of Science, MEDLINE, PubMed, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Journal of Surgical Oncology open access, and what is the APC?
Journal of Surgical Oncology is a hybrid journal. For open-access publication: APC about USD 4,570.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .